Boston Scientific (BSX) Closes Acquisition of Neovasc (NVCN) Advanced Biological Tissue Capabilities, Acquires 15% Stake

December 13, 2016 7:04 AM EST Send to a Friend
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of certain manufacturing assets and capabilities of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login